Company profile
Relmada Therapeutics company profile
Relmada Therapeutics is a late-stage biotechnology company addressing diseases of the central nervous system (CNS), with a focus on major depressive disorder (MDD). Our experienced and dedicated team is committed to making a difference in the lives of patients and their families. Relmada' s lead program, REL-1017, is a novel NMDA receptor (NMDAR) channel blocker that preferentially targets hyperactive channels while maintaining physiological glutamatergic neurotransmission. REL-1017 has entered late-stage development as an adjunctive treatment for MDD in adults.()
Business identity
- Website
- http://www.relmada.com
- Contact email
- [email protected]
- Phone number
- 646-876-3459
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2004-01-01, Year
Headquarters
- Headquarters
- Troy, New Hampshire, United States
- Postal code
- 10022
- Country code
- US
- Continent
- North America